GC Rieber VivoMega now operates on 100% renewable energy

News
Article

GC Rieber VivoMega has announced that its three omega-3 facilities are running on 100% renewable energy after having implemented an electric steam boiler to power its marine and microalgae omega-3 operations.

Electric steam boiler. Image courtesy of GC Rieber VivoMega.

Electric steam boiler. Image courtesy of GC Rieber VivoMega.

GC Rieber VivoMega (Norway) has announced that its three omega-3 facilities are running on 100% renewable energy after having implemented an electric steam boiler to power its marine and microalgae omega-3 operations. According to the company, the boiler’s initial output is 7.5 MW, but the output can be doubled should the need arise. This allows the company to supply its factories with 25GWh of steam annually to produce its marine and vegan omega-3 concentrates.

“The energy supplied comes from our green hydropower plants and replaces our oil boiler that burned fish oil for energy. This means that the fish oil we burned previously can instead be repurposed into the food chain to produce fish feed and that GC Rieber VivoMega emissions will be vastly diminished,” said Frode Jenssen, COO of GC Rieber VivoMega, in a press release. “In the next few years, we seek to only consume green energy from biodiesel and electricity and discontinue fossil fuels. We are extremely proud of this additional investment to further our dedication to sustainable and environmentally friendly practices.”

According to the company’s press release, nearly all of Norway’s electricity production comes from renewable sources, with hydropower being the main source. Hydropower produces no air pollutants and has the lowest greenhouse gas emissions of all power generation technologies, says GC Rieber VivoMega. Its VivoMega boiler is a standing cylindrical, fully welded steam boiler built in accordance with PED 2014/68/EU.

Recent Videos
Nils Hoem and Nutritional Outlook editor Sebastian Krawiec
woman working on laptop computer by window
Related Content
© 2024 MJH Life Sciences

All rights reserved.